WallStSmart

Corteva Inc (CTVA)vsICL Israel Chemicals Ltd (ICL)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

ICL Israel Chemicals Ltd generates 55% more annual revenue ($7.71B vs $4.97B). ICL leads profitability with a 4.0% profit margin vs 2.8%. CTVA appears more attractively valued with a PEG of 0.62. ICL earns a higher WallStSmart Score of 62/100 (C+).

CTVA

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 5.0Value: 8.0Quality: 6.5
Piotroski: 5/9Altman Z: 1.49

ICL

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 5.0Value: 4.7Quality: 6.0
Piotroski: 2/9Altman Z: 2.13
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTVAUndervalued (+3.4%)

Margin of Safety

+3.4%

Fair Value

$12.53

Current Price

$9.19

$3.34 discount

UndervaluedFair: $12.53Overvalued
ICLUndervalued (+0.2%)

Margin of Safety

+0.2%

Fair Value

$5.76

Current Price

$4.59

$1.17 discount

UndervaluedFair: $5.76Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 9.3/10
P/E RatioValuation
7.2x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.628/10

Growing faster than its price suggests

ICL3 strengths · Avg: 9.3/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

EPS GrowthGrowth
51.6%10/10

Earnings expanding 51.6% YoY

Revenue GrowthGrowth
16.5%8/10

16.5% revenue growth

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

EPS GrowthGrowth
-9.9%2/10

Earnings declined 9.9%

ICL4 concerns · Avg: 2.8/10
Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
9.442/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on P/E Ratio, Price/Book, Debt/Equity. PEG of 0.62 suggests the stock is reasonably priced for its growth.

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth, Revenue Growth. Revenue growth of 16.5% demonstrates continued momentum.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, Revenue Growth. Thin 2.8% margins leave little buffer for downturns.

Bear Case : ICL

The primary concerns for ICL are Return on Equity, Profit Margin, Piotroski F-Score. Thin 4.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

CTVA profiles as a value stock while ICL is a growth play — different risk/reward profiles.

ICL carries more volatility with a beta of 1.00 — expect wider price swings.

ICL is growing revenue faster at 16.5% — sustainability is the question.

ICL generates stronger free cash flow (93M), providing more financial flexibility.

Bottom Line

ICL scores higher overall (62/100 vs 52/100) and 16.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Want to dig deeper into these stocks?